Lahore: Highnoon Laboratories Limited has announced a forthcoming meeting of its Board of Directors, scheduled for Tuesday, October 27, 2026, at its corporate office in Lahore. The board will convene to examine and approve the un-audited financial statements for the third quarter ending September 30, 2026, among other agenda items.

In compliance with the Pakistan Stock Exchange regulations, the company has instituted a "Closed Period" from October 20, 2026, to October 27, 2026. During this time, as mandated by clause 5.6.4. of the PSX Regulations, no Director, CEO, or Executive is permitted to engage in any form of direct or indirect dealings in the company's shares.

According to information available from the Pakistan Stock Exchange (PSX), such measures ensure transparency and compliance with regulatory standards. Highnoon Laboratories Limited, listed under the pharmaceutical sector of the PSX, adheres strictly to these governance protocols to maintain market integrity.

The board meeting will provide critical insights into the company's financial health and operational performance for the recent quarter, informing stakeholders and guiding future strategic decisions.